Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio Read more about Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting Read more about Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference Read more about Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors Read more about Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy Read more about Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
Labcorp to Webcast Its Annual Meeting of Shareholders Read more about Labcorp to Webcast Its Annual Meeting of Shareholders
Invitae Receives Court Approval for Sale to Labcorp Read more about Invitae Receives Court Approval for Sale to Labcorp
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Read more about Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Labcorp Announces 2024 First Quarter Results Read more about Labcorp Announces 2024 First Quarter Results
Labcorp Announces Winning Bid for Select Assets of Invitae Read more about Labcorp Announces Winning Bid for Select Assets of Invitae
